MedPath

ANSATIPIN 150 MG CÁPSULAS DURAS

ANSATIPIN 150 MG CÁPSULAS DURAS

Commercialized
Register Number

60228

Prescription Type

Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración

Authorization Date

Nov 30, 1994

Dosage Form

CÁPSULA DURA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number60228
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

RIFABUTINAActive
Quantity: 150 mg
Name: RIFABUTINA

ATC CLASSIFICATION (3)

J04A
J04AB
J04AB04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.